Nilvadipine

HCID 4494CAS 75530-68-6

기본 정보

표준 SMILES
COC(=O)C1=C(C#N)NC(C)=C(C(=O)OC(C)C)C1c1cccc([N+](=O)[O-])c1
InChIKey
FAIIFDPAEUKBEP-UHFFFAOYSA-N
분자식
C19H19N3O6
평균 분자량
385.4 g/mol
단동위원소 질량
385.12738533

이름 및 식별자

우선 이름
Nilvadipine
IUPAC
3-O-methyl 5-O-propan-2-yl 2-cyano-6-methyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
영어명
Nilvadipine
분자식
C19H19N3O6
분자량
385.37

이름 및 동의어

nilvadipine75530-68-6EscorNivadilNivadipineFR-34235NilvadipinoNivadipFK 235NilvadipinumDl-nilvadipineFK-235
이름 더 보기
SKF-fk235ARC029CL 287389BAY-e-6927SKF-102362
SK&F 102,362CL 287,389DTXSID2046624SK&F-102362CL-287389SK&F-102,3620214FUT37JCL-287,389

데이터베이스 식별자

CAS
75530-68-6
PubChem CID
4494
DTXSID
DTXSID2046624
ChEMBL
CHEMBL517427
ChEBI
CHEBI:31911
UNII
0214FUT37J
EC Number
805-887-5
Nikkaji
J22.253D

물성

구조 계산 물성

XLogP
2.9
극성 표면적
134 Ų
수소 결합 공여자 수
1
수소 결합 수용자 수
8
회전 가능 결합 수
6
무거운 원자 수
28

실험 및 물리화학적 성질

Physical DescriptionSolid
Kovats Retention Index2729.22

물리화학적 성질

녹는점
148 · 148-150°C
끓는 점
511.83 °C · 511.83°C (rough estimate)
밀도
1.3937 · 1.3937 (rough estimate)
굴절률
1.59 · 1.5900 (estimate)
저장 조건
2 · Keep in dark place,Sealed in dry,2-8°C
용해도
15 mg/mL, · DMSO: 용해성15mg/mL, 투명

화학적 성질

Yellow Prisms

안전 및 규제

GHS 분류

GHS Classification · 5건

Warning

H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]

P264, P270, P301+P317, P330, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 39 reports by companies from 2 notifications to the ECHA C&L Inventory.;Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website.

유해성 정보

Hazard Classes and CategoriesAcute Tox. 4 (100%)

안전 데이터

wgk
3
rtecs
US7968300
독성
LD50 oral in rat: 1560mg/kg
HS 번호
2933.39.9200
risk_code
22
hazard_code
Xn

화학 및 산업

약리 정보

ATC Code · 2건

C - Cardiovascular system;C08 - Calcium channel blockers;C08C - Selective calcium channel blockers with mainly vascular effects;C08CA - Dihydropyridine derivatives;C08CA10 - Nilvadipine

QC - Cardiovascular system;QC08 - Calcium channel blockers;QC08C - Selective calcium channel blockers with mainly vascular effects;QC08CA - Dihydropyridine derivatives;QC08CA10 - Nilvadipine

Pharmacodynamics · 1건

Nilvadipine is similar to other dihydropyridines including amlodipine, felodipine, isradipine, and nicardipine. Nilvadipine is used to treat Prinzmetal's angina, hypertension, and other vascular disorders such as Raynaud's phenomenon. By blocking the calcium channels, Nifedipine inhibits the spasm of the coronary artery and dilates the systemic arteries, results in a increase of myocardial oxygen supply and a decrease in systemic blood pressure.

Mechanism of Action · 1건

Nilvadipine inhibits the influx of extracellular calcium through myocardial and vascular membrane pores by physically plugging the channel. The decrease in intracellular calcium inhibits the contractile processes of smooth muscle cells, causing dilation of the coronary and systemic arteries, increased oxygen delivery to the myocardial tissue, decreased total peripheral resistance, decreased systemic blood pressure, and decreased afterload.

MeSH Pharmacological Classification · 2건

Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS.

A class of drugs that act by selective inhibition of calcium influx through cellular membranes.

Cellular LocationsMembrane

용도 및 제조

UsesUse (kg; approx.) in Germany (2009): >50;Consumption (g per capita; approx.) in Germany (2009): 0.000611;Calculated removal (%): 24.5
응용 분야 · 1건

개요Nilvadipine is a new, second-generation calcium channel blocker effective in the treatment of hypertension and angina pectoris. Its potent inhibitory effect on the stimulated chemotaxis of smooth muscle cells and protective action against calcium deposition suggest that nilvadipine may be useful for preventing and treating atherosclerosis.

공급사50 곳

北京华美互利生物化工010-56205725 · [email protected]
梯希爱(上海)化成工业发展有限公司021-67121386 · [email protected]
阿诺西(上海)生物技术有限公司400-1107768 15058188853 · [email protected]
上海阿拉丁生化科技股份有限公司400-6206333 13167063860 · [email protected]
济南百隆化学有限公司[email protected] · [email protected]

관련 반응

7건

연결된 노트

불러오는 중…